4 Results

People

  1. Bornmann
    Bornmann
  2. Clarkson
    Clarkson
  3. Moore
    Moore
  4. Morrone
    Morrone
  5. Shieh
    Shieh
  6. Steinherz
    Steinherz
  7. Veach
    Veach
  8. Warrell
    Warrell
  9. Ye
    Ye

Groups

  1. Sloan Kettering Institute Faculty (2)
  2. Cell Biology Program Faculty (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. Hematologic Malignancies Service (1)
  6. Hematologic Malignancies, Division of (1)
  7. Molecular Pharmacology and Chemistry Program Faculty (1)
  8. Pediatric Leukemia (1)
  9. Pediatrics, Department of (1)
  10. Radiochemistry and Imaging Sciences Service (1)
  1. "article"
  2. "Leukemia"
  3. "2004"
Formats
  1. Journal Article (4)
Groups
  1. Sloan Kettering Institute Faculty (2)
  2. Cell Biology Program Faculty (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. Hematologic Malignancies Service (1)
  6. Hematologic Malignancies, Division of (1)

More Groups

People
  1. Bayard Clarkson (1)
  2. Darren Veach (1)
  3. Giovanni Morrone (1)
  4. Jae-Hung Shieh (1)
  5. Malcolm Moore (1)
  6. Peter Steinherz (1)

More People

Years
  1. 2004 (4)
Publications
  1. Leukemia (4)
Publishers
  1. Nature Publishing Group (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors
    Journal Article

    Ye, Q.; Shieh, J.H.; Morrone, G.; Moore, M. A. S.
    Leukemia (2004)

    Fulltext@MSK | Save
  • Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: A report from the Children's Cancer Group
    Journal Article

    Heerema, N. A.; Nachman, J. B.; Sather, H. N.; La, M. K.; Hutchinson, R.; Lange, B. J.; Bostrom, B.; Steinherz, P. G.; Gaynon, P. S.; Uckun, F. M.
    Leukemia (2004)

    Fulltext@MSK | Save
  • Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate
    Journal Article

    Tipping, A. J.; Baluch, S.; Barnes, D. J.; Veach, D. R.; Clarkson, B.; Bornmann, W. G.; Mahon, F. X.; Goldman, J. M.; Melo, J. V.
    Leukemia (2004)

    Fulltext@MSK | Save
  • Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide
    Journal Article

    Sun, Y.; Kim, S. H.; Zhou, D. C.; Ding, W.; Paietta, E.; Guidez, F.; Zelent, A.; Ramesh, K. H.; Cannizzaro, L.; Warrell, R. P. Jr; more...
    Leukemia (2004)

    Fulltext@MSK | Save